Bristol-Myers Squibb claims glucocorticoid receptor modulators for the treatment of obesity May 28, 2009
GlaxoSmithKline discovers novel chemokine CCR5 receptor antagonists for the treatment of HIV May 28, 2009
Orchid Chemicals & Pharmaceuticals describes novel HDAC inhibitors as oncolytic compounds May 28, 2009
Bristol-Myers Squibb discloses androgen receptor antagonists for the treatment of cancer May 27, 2009